The illicit generation of tetraploid cells constitutes a prominent driver of oncogenesis, as it often precedes the development of aneuploidy and genomic instability. In addition, tetraploid (pre-)malignant cells display an elevated resistance against radio- and chemotherapy. Here, we report a strategy to preferentially kill tetraploid tumor cells based on the broad-spectrum kinase inhibitor SP600125. Live videomicroscopy revealed that SP600125 affects the execution of mitosis, impedes proper cell division and/or activates apoptosis in near-to-tetraploid, though less so in parental, cancer cells. We propose a novel graphical model to quantify the differential response of diploid and tetraploid cells to mitotic perturbators, including SP600125, which we baptized "transgenerational cell fate profiling." We speculate that this representation constitutes a valid alternative to classical "single-cell fate" and "genealogical" profiling and, hence, may facilitate the analysis of cell fate within a heterogeneous population as well as the visual examination of cell cycle alterations.
Ilio Vitale, Lorenzo Galluzzi, Sonia Vivet, Lisa Nanty, Laura Senovilla, Ken A. Olaussen, Vladimir Lazar, Roy M. Golsteyn, Maria Castedo, Guido Guido Kroemer
Ilio Vitale, Lorenzo Galluzzi, Sonia Vivet, Lisa Nanty, Philippe Dessen, Laura Senovilla, Ken A. Olaussen, Vladimir Lazar, Michelle Prudhomme, Roy M. Golsteyn, Maria Castedo, Guido Guido Kroemer
Ilio Vitale, Mohamed Jèmaà, Laura Senovilla, Lorenzo Galluzzi, Santiago Rello‐Varona, Didier Métivier, Hugues Ripoche, Vladimir Lazar, Philippe Dessen, Maria Castedo, Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.